These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35142992)
1. Development of Duramycin-Based Molecular Probes for Cell Death Imaging. Zhang D; Gao M; Jin Q; Ni Y; Li H; Jiang C; Zhang J Mol Imaging Biol; 2022 Aug; 24(4):612-629. PubMed ID: 35142992 [TBL] [Abstract][Full Text] [Related]
3. Targeting Phosphatidylethanolamine with Fluorine-18 Labeled Small Molecule Probe for Apoptosis Imaging. Yuan G; Liu S; Ma H; Su S; Wen F; Tang X; Zhang Z; Zhao J; Lin L; Xiang X; Nie D; Tang G Mol Imaging Biol; 2020 Aug; 22(4):914-923. PubMed ID: 31828718 [TBL] [Abstract][Full Text] [Related]
4. [ Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197 [TBL] [Abstract][Full Text] [Related]
5. A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin. Zhao M; Li Z Nucl Med Biol; 2012 Oct; 39(7):1006-11. PubMed ID: 22858374 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis. Elvas F; Stroobants S; Wyffels L Apoptosis; 2017 Aug; 22(8):971-987. PubMed ID: 28623512 [TBL] [Abstract][Full Text] [Related]
7. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model. Wang L; Wang F; Fang W; Johnson SE; Audi S; Zimmer M; Holly TA; Lee DC; Zhu B; Zhu H; Zhao M Nucl Med Biol; 2015 Feb; 42(2):198-204. PubMed ID: 25451214 [TBL] [Abstract][Full Text] [Related]
8. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
9. Exploring the potential of radiolabeled duramycin as an infection imaging probe. Kumar A; Mitra JB; Khatoon E; Pramanik A; Sharma RK; Chandak A; Rakshit S; Mukherjee A Drug Dev Res; 2024 Feb; 85(1):e22138. PubMed ID: 38078492 [TBL] [Abstract][Full Text] [Related]
13. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin. Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031 [TBL] [Abstract][Full Text] [Related]
14. Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis. Elvas F; Vangestel C; Rapic S; Verhaeghe J; Gray B; Pak K; Stroobants S; Staelens S; Wyffels L Mol Imaging Biol; 2015 Dec; 17(6):838-47. PubMed ID: 25896815 [TBL] [Abstract][Full Text] [Related]
15. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. Zhao M; Li Z; Bugenhagen S J Nucl Med; 2008 Aug; 49(8):1345-52. PubMed ID: 18632826 [TBL] [Abstract][Full Text] [Related]
16. Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer. Li J; Gray BD; Pak KY; Ng CK Nucl Med Biol; 2019; 78-79():23-30. PubMed ID: 31678784 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Chemotherapy-Induced Organ Damage with Ga-68 Labeled Duramycin. Rix A; Drude NI; Mrugalla A; Baskaya F; Pak KY; Gray B; Kaiser HJ; Tolba RH; Fiegle E; Lederle W; Mottaghy FM; Kiessling F Mol Imaging Biol; 2020 Jun; 22(3):623-633. PubMed ID: 31396770 [TBL] [Abstract][Full Text] [Related]
18. A Comparison of [ Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938 [TBL] [Abstract][Full Text] [Related]
19. Tan H; Abudupataer M; Qiu L; Mao W; Xiao J; Cheng D; Shi H Chem Biol Drug Des; 2021 Feb; 97(2):210-220. PubMed ID: 32881342 [TBL] [Abstract][Full Text] [Related]